Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 736563, 10 pages
http://dx.doi.org/10.1155/2014/736563
Research Article

Effect of Sipjeondaebo-Tang on Cancer-Induced Anorexia and Cachexia in CT-26 Tumor-Bearing Mice

1Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea
2Department of Oriental Internal Medicine, College of Oriental Medicine, Gachon University, Seongnam, Republic of Korea

Received 17 February 2014; Accepted 23 April 2014; Published 14 May 2014

Academic Editor: Bing Du

Copyright © 2014 Youn Kyung Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. D. Dewys, C. Begg, and P. T. Lavin, “Prognostic effect of weight loss prior to chemotherapy in cancer patients,” The American Journal of Medicine, vol. 69, no. 4, pp. 491–497, 1980. View at Google Scholar · View at Scopus
  2. J. K. Brown, “A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia,” Oncology Nursing Forum, vol. 29, no. 3, pp. 517–532, 2002. View at Google Scholar · View at Scopus
  3. K. C. Fearon, A. C. Voss, and D. S. Hustead, “Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis,” The American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1345–1350, 2006. View at Google Scholar · View at Scopus
  4. E. J. B. Ramos, S. Suzuki, D. Marks, A. Inui, A. Asakawa, and M. M. Meguid, “Cancer anorexia-cachexia syndrome: cytokines and neuropeptides,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 7, no. 4, pp. 427–434, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. N. Gordon, S. R. Green, and P. M. Goggin, “Cancer cachexia,” Monthly Journal of the Association of Physicians, vol. 98, no. 11, pp. 779–788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Tisdale, “Cachexia in cancer patients,” Nature Reviews Cancer, vol. 2, no. 11, pp. 862–871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. K. C. H. Fearon and A. G. W. Moses, “Cancer cachexia,” International Journal of Cardiology, vol. 85, no. 1, pp. 73–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Theologides, “Cancer cachexia,” Cancer, vol. 43, supplement 5, pp. 2004–2012, 1979. View at Google Scholar · View at Scopus
  9. M. Muscaritoli, M. Bossola, Z. Aversa, R. Bellantone, and F. Rossi Fanelli, “Prevention and treatment of cancer cachexia: new insights into an old problem,” European Journal of Cancer, vol. 42, no. 1, pp. 31–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Niwa, M. Hashimoto, S. Morishita et al., “Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17β-induced endometrial carcinogenesis in mice,” Carcinogenesis, vol. 22, no. 4, pp. 587–591, 2001. View at Google Scholar · View at Scopus
  11. A. F. Sawalha, W. M. Sweileh, S. H. Zyoud, and S. W. Jabi, “Self-therapy practices among university students in Palestine: focus on herbal remedies,” Complementary Therapies in Medicine, vol. 16, no. 6, pp. 343–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Matsumoto, M. H. Sakurai, H. Kiyohara, and H. Yamada, “Orally administered decoction of Kampo (Japanese herbal) medicine, “Juzen-Taiho-To” modulates cytokine secretion and induces NKT cells in mouse liver,” Immunopharmacology, vol. 46, no. 2, pp. 149–161, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Saiki, “A Kampo medicine “Juzen-taiho-to”—prevention of malignant progression and metastasis of tumor cells and the mechanism of action,” Biological and Pharmaceutical Bulletin, vol. 23, no. 6, pp. 677–688, 2000. View at Google Scholar · View at Scopus
  14. M. Utsuyama, H. Seidlar, M. Kitagawa, and K. Hirokawa, “Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice,” Mechanisms of Ageing and Development, vol. 122, no. 3, pp. 341–352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Haranaka, R. Hasegawa, S. Nakagawa, A. Sakurai, N. Satomi, and K. Haranaka, “Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC,” Journal of Biological Response Modifiers, vol. 7, no. 1, pp. 77–90, 1988. View at Google Scholar · View at Scopus
  16. K. Sugiyama, H. Ueda, Y. Ichio, and M. Yokota, “Improvement of cisplatin toxicity and lethality by Juzen-taiho-to in mice,” Biological and Pharmaceutical Bulletin, vol. 18, no. 1, pp. 53–58, 1995. View at Google Scholar · View at Scopus
  17. Y. Onishi, T. Yamaura, K. Tauchi et al., “Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents,” Biological and Pharmaceutical Bulletin, vol. 21, no. 7, pp. 761–765, 1998. View at Google Scholar · View at Scopus
  18. Y. Ohnishi, H. Fujii, F. Kimura et al., “Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma,” Japanese Journal of Cancer Research, vol. 87, no. 10, pp. 1039–1044, 1996. View at Google Scholar
  19. Y. Ohnishi, H. Fujii, Y. Hayakawa et al., “Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells,” Japanese Journal of Cancer Research, vol. 89, no. 2, pp. 206–213, 1998. View at Google Scholar · View at Scopus
  20. P. Aulino, E. Berardi, V. M. Cardillo et al., “Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse,” BMC Cancer, vol. 10, article 363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Tisdale, “Mechanisms of cancer cachexia,” Physiological Reviews, vol. 89, no. 2, pp. 381–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Michalak, M. Wender, and G. Michałowska-Wender, “Cachexia—induced cerebellar degeneration: involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease,” Acta Neurobiologiae Experimentalis, vol. 66, no. 2, pp. 113–122, 2006. View at Google Scholar · View at Scopus
  23. P. J. Havel, “Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis,” Experimental Biology and Medicine, vol. 226, no. 11, pp. 963–977, 2001. View at Google Scholar · View at Scopus
  24. C. W. Le Roux, S. J. B. Aylwin, R. L. Batterham et al., “Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters,” Annals of Surgery, vol. 243, no. 1, pp. 108–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Dhanapal, T. R. Saraswathi, and N. Govind Rajkumar, “Cancer cachexia,” Journal of Oral and Maxillofacial Pathology, vol. 15, no. 3, pp. 257–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. K. Bedi and P. D. Shenefelt, “Herbal therapy in dermatology,” Archives of Dermatology, vol. 138, no. 2, pp. 232–242, 2002. View at Google Scholar · View at Scopus
  27. O. Olaku and J. D. White, “Herbal therapy use by cancer patients: a literature review on case reports,” European Journal of Cancer, vol. 47, no. 4, pp. 508–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Y. Yin, W. C. Wei, F. Y. Jian, and N. S. Yang, “Therapeutic applications of herbal medicines for cancer patients,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 302426, 15 pages, 2013. View at Publisher · View at Google Scholar
  29. H. Hisha, H. Yamada, M. H. Sakurai et al., “Isolation and identification of hematopoietic stem cell-stimulating substances from Kampo (Japanese herbal) medicine, Juzen-taiho-to,” Blood, vol. 90, no. 3, pp. 1022–1030, 1997. View at Google Scholar
  30. G. Mantovani, A. Macciò, C. Madeddu et al., “Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites,” Journal of Molecular Medicine, vol. 79, no. 7, pp. 406–414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. G. Catalano, N. Fortunati, K. Arena et al., “Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia,” International Journal of Oncology, vol. 23, no. 2, pp. 429–436, 2003. View at Google Scholar · View at Scopus
  32. H. R. Scott, D. C. McMillan, A. Crilly, C. S. McArdle, and R. Milroy, “The relationship between weight loss and interleukin 6 in non-small-cell lung cancer,” The British Journal of Cancer, vol. 73, no. 12, pp. 1560–1562, 1996. View at Google Scholar
  33. A. G. W. Moses, J. Maingay, K. Sangster, K. C. H. Fearon, and J. A. Ross, “Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival,” Oncology Reports, vol. 21, no. 4, pp. 1091–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. S. Hong, L. S. Angelo, and R. Kurzrock, “Interleukin-6 and its receptor in cancer: implications for translational therapeutics,” Cancer, vol. 110, no. 9, pp. 1911–1928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Wolf, S. Sadetzki, H. Kanely et al., “Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients,” Cancer, vol. 106, no. 4, pp. 966–973, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Dicato, L. Plawny, and M. Diederich, “Anemia in cancer,” Annals of Oncology, vol. 21, supplement 7, pp. vii167–vii172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Glaspy, L. Degos, M. Dicato, and G. D. Demetri, “Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials,” Oncologist, vol. 7, no. 2, pp. 126–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. R. D. Cone, “Anatomy and regulation of the central melanocortin system,” Nature Neuroscience, vol. 8, no. 5, pp. 571–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. E. T. Rolls, “Smell, taste, texture, and temperature multimodal representations in the brain, and their relevance to the control of appetite,” Nutrition Reviews, vol. 62, no. 11, pp. S193–S204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Inui, “Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin,” Trends in Neurosciences, vol. 22, no. 2, pp. 62–67, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Sonti, S. E. Ilyin, and C. R. PlataSalaman, “Anorexia induced by cytokine interactions at pathophysiological concentrations,” The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 270, no. 6, part 2, pp. R1394–R1402, 1996. View at Google Scholar
  42. L. L. Moldawer, M. A. Rogy, and S. F. Lowry, “The role of cytokines in cancer cachexia,” Journal of Parenteral and Enteral Nutrition, vol. 16, supplement 6, pp. 43S–49S, 1992. View at Google Scholar · View at Scopus
  43. N. MacDonald, A. M. Easson, V. C. Mazurak, G. P. Dunn, and V. E. Baracos, “Understanding and managing cancer cachexia,” Journal of the American College of Surgeons, vol. 197, no. 1, pp. 143–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. C. R. Plata-Salamán, S. E. Ilyin, and D. Gayle, “Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells,” The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 275, no. 2, pp. R566–R573, 1998. View at Google Scholar · View at Scopus
  45. C. C. Gerhardt, I. A. Romero, R. Cancello, L. Camoin, and A. D. Strosberg, “Chemokines control fat accumulation and leptin secretion by cultured human adipocytes,” Molecular and Cellular Endocrinology, vol. 175, no. 1-2, pp. 81–92, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Ishibashi, Y. Nishino, T. Matsui, M. Takeuchi, and S. I. Yamagishi, “Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level,” Metabolism: Clinical and Experimental, vol. 60, no. 9, pp. 1271–1277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Kihira, M. Miyake, M. Hirata et al., “Deletion of hypoxia-inducible factor-1alpha in adipocytes enhances glucagon-like Peptide-1 secretion and reduces adipose tissue inflammation,” PLoS ONE, vol. 9, no. 4, Article ID e93856, 2014. View at Publisher · View at Google Scholar
  48. R. Shirazi, V. Palsdottir, J. Collander et al., “Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 40, pp. 16199–16204, 2013. View at Publisher · View at Google Scholar
  49. Y. S. Lee, M. S. Park, J. S. Choung et al., “Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes,” Diabetologia, vol. 55, no. 9, pp. 2456–2468, 2012. View at Publisher · View at Google Scholar
  50. H. Ellingsgaard, I. Hauselmann, B. Schuler et al., “Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells,” Nature Medicine, vol. 17, no. 11, pp. 1481–1489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Garcia, M. Garcia-Touza, R. A. Hijazi et al., “Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2920–2926, 2005. View at Publisher · View at Google Scholar · View at Scopus